Literature DB >> 2660680

Structure of heparin and heparin fragments.

B Casu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2660680     DOI： 10.1111/j.1749-6632.1989.tb22485.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  12 in total

1.  Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone-labeled disaccharides with LC-fluorescence and LC-MS detection.

Authors:  Nicola Volpi; Fabio Galeotti; Bo Yang; Robert J Linhardt
Journal:  Nat Protoc       Date:  2014-02-06       Impact factor: 13.491

Review 2.  Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.

Authors:  J Marc Simard; David Schreibman; E Francois Aldrich; Bernadette Stallmeyer; Brian Le; Robert F James; Narlin Beaty
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

3.  Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats.

Authors:  Mehmet Yalniz; Ulvi Demirel; Cemal Orhan; Ibrahim Halil Bahcecioglu; Ibrahim Hanefi Ozercan; Cem Aygun; Mehmet Tuzcu; Kazim Sahin
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

4.  Low-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma.

Authors:  Brijeshkumar Patel; Nilesh Gupta; Fakhrul Ahsan
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-11-28       Impact factor: 2.849

5.  Hemocompatibility of poly(ether imide) membranes functionalized with carboxylic groups.

Authors:  R Tzoneva; B Seifert; W Albrecht; K Richau; T Groth; A Lendlein
Journal:  J Mater Sci Mater Med       Date:  2008-05-02       Impact factor: 3.896

Review 6.  Heparan sulfate and heparin interactions with proteins.

Authors:  Maria C Z Meneghetti; Ashley J Hughes; Timothy R Rudd; Helena B Nader; Andrew K Powell; Edwin A Yates; Marcelo A Lima
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

7.  Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo.

Authors:  L A Pukac; G M Hirsch; J C Lormeau; M Petitou; J Choay; M J Karnovsky
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

8.  Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment.

Authors:  J Marc Simard; E Francois Aldrich; David Schreibman; Robert F James; Adam Polifka; Narlin Beaty
Journal:  J Neurosurg       Date:  2013-09-13       Impact factor: 5.115

9.  Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.

Authors:  H C Whinna; F C Church
Journal:  J Protein Chem       Date:  1993-12

10.  Benefits and risks of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.

Authors:  Mingjin Yang; Ying Xu; Hong Chen; Zhibo Xu; Fengming Luo
Journal:  Inflammopharmacology       Date:  2019-10-31       Impact factor: 4.473
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.